Jason Stumpff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Luke Awtry From left: Sarah Vandal; Katie Queen; Hannah Poquette; Katie Schutt, PhD; Alex Thompson; Jason Stumpff, PhD; Carolyn Marquis; Leslie Sepaniac; and Cindy Fonseca, MS Significant advances in the fight against cancer aren't always made by a single inspired scientist; often they're accomplished by a team. The University of Vermont Cancer Center excels at supporting and promoting team science. Sometimes, those teams even include undergraduate students a...

Related Company:  Larner College of Medicine faculty Gary and Janet Stein are principal investigators on a new $9 million grant from the National Cancer Institute to explore the epigenetics of breast cancer with the goal of finding new drug targets. (Photos: Sally McCay, Larner College of Medicine) Project to Identify New Targets for Drug Treatment That Could Prevent or Halt Disease Vermont Business Magazine A team of University of Vermont scientists and physician investigators at the UVM Cancer Center and the Northern New England Clinical and Translational Research Network has been awarded ...

The theses projects of two former undergrads, Lisa Wood (left) and Carolyn Marquis (right), were important contributors to new research that holds promising discoveries in the fight against cancer. Wood and Marquis pursued this work in the lab of the study’s lead author and UVM Cancer Center researcher Jason Stumpff. At center is a triple negative breast cancer cell, used to demonstrate a vulnerability that could be a potential target for interrupting cancer cell growth. (Photos: Courtesy of Lisa Wood, Cindy Fonseca and Carolyn Marquis) When the University of Vermont announced last we...

 E-Mail Unravelling the unique characteristics of cancer cells and finding less-harmful ways to stop their growth have long been a focus for cancer researchers worldwide. New findings, reported in Nature Communications, describe the discovery of a unique dependence of cancer cells on a particular protein, which could lead to desperately needed treatment for hard-to-treat cancers. The publication caps off a series of groundbreaking studies appearing in Nature journals over the last month by members of a powerful international research collaboration. Lead author and University of Vermont (U...

  Image of a triple negative breast cancer cell undergoing abnormal division after inhibition of KIF18A. (Credit: Cindy Fonseca, Stumpff Lab, UVM) Vermont Business Magazine Unraveling the unique characteristics of cancer cells and finding less-harmful ways to stop their growth have long been a focus for cancer researchers worldwide. New findings, reported today in Nature Communications, describe the discovery of a unique dependence of cancer cells on a particular protein, which could lead to desperately-needed treatment for hard-to-treat cancers. The publication caps off a series of groundb...